The epidemic of opioid addiction in the US is unlikely to become the next asbestos for the (re)insurance industry, WR Berkley president and CEO Robert Berkley has said.
The epidemic of opioid addiction in the US is unlikely to become the next asbestos for the (re)insurance industry, WR Berkley president and CEO Robert Berkley has said.